The Right Heart Diaries in Sleep Disordered Breathing

Abstract

Keywords

• -

The Right Heart Diaries in Sleep Disordered Breathing

Öz

-

Anahtar Kelimeler

• -

Kaynakça

1. Young T, Palte M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328:1230-1235
2. Rafanan AL, Golish JA, Dinner DS. Nocturnal hypoxemia is common in primary pulmonary hypertension.Chest 2001; 120:894-899
3. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995:1897-1904
4. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea–hypopnoea with or without treatment with con- tinuous positive airway pressure: an observational study. Lancet 2005; 305:1046–1053
5. Motley HL, Cournand A, Werko L, Himmelstein A, Dresdale D. The influence of short periods of induced acute anoxia upon pulmonary artery pressures in man. Am J Physiol 1947;150:315–320
6. Barst RJ, McGoon M, Torbicki A, et al. Diagnosis and dif- ferential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43:40S–47S
7. Marrone O, Bonsignore MR. Pulmonary haemodynamics in obstructive sleep apnoea. Sleep Med Rev 2002; 6
8. Krishnan V, Hassaun P, Hummers L, Collop NA. Sleep dis- ordered breathing and pulmonary hypertension. Sleep. 2005;20:A300.

9. Simonneau G, Galiè N,Rubin LJ, et al. Clinical classifica- tion of pulmonary hypertension. Am Coll Cardiol 2004 Jun 16;43:5-12
10. Veerman DP, İmholz BP, Wieling W, Wesseling KH, van Montfrans GA. Circadian profile of systemic hemodynam- ics. Hypertension 1995;26:55-9.
11. Rowlands DB ST, Watson RDS, Littler WA. The influence of physical activity on arterial pressure during ambulatory recordings in man. Clin Sci 1980; 58:115-117
12. Mann S, Craig MW, Melville DI, Balasubramanian V, Raftery EB. Physical activity and the circadian rhythm of blood pressure. Clin Sci 1979; 57:291-294
13. Somers VK Dyken ME, Mark AL, Abboud FM. Sympathetic- nerve activity during sleep in normal subjects. N Engl J Med 1993; 328:303-307
14. Mancia G. Autonomic modulation of the cardiovascular system during sleep. N Eng J Med 1993; 328
15. Bakshi MS, Hoskere G, Mehta JB, Chidambaram B, Ponder M, Girish MR. Circulatory response in sleep apnea pa- tients during sleep before and after CPAP treatment. Sleep. 2005;20:A194
16. Bonsignore MR, Marrone O, Insalaco G, Bonsignore G. The cardiovascular effects of obstructive sleep apnoeas: analysis of pathogenic mechanisms. Eur Respir J 1994; 7:786-805
17. Marrone O, Bellia V, Ferrara G, et al. Transmural pres- sure measurements. İmportance in the assessment of pul- monary hypertension in obstructive sleep apneas. Chest 1989; 95:338-342
18. Marrone O, Romano S. Pulmonary artery pressure in ob- structive apneas: influence of intrathoracic pressure and hypoxia. Am Rev Respir Dis 1993; 147:1017
19. Phillips BG, Narkiewicz K, Pesek CA, Haynes WG, Dyken ME, SomersVK. Effects of obstructive sleep apnea on en- dothelin-1 and blood pressure. J Hypertens. 1999;17:61– 66.
20. Carpagnano GE, Spanevello A, Sabato R, et al. Exhaled pH, exhaled nitric oxide, and induced sputum cellularity in obese patients with obstructive sleep apnea syndrome. Transl Res. 2008 Jan;151(1):45-50.
21. Ahmed Q, Chung-Park M, Tomashefski J. Cardiopulmonary pathology in patients with sleep apnea/obesity hypoven- tilation syndrome. Hum Pathol 1997;28:264–269
22. Sajkov D, Cowie RJ, Thornton AT, Espinoza HA, McEvoy RD Pulmonary hypertension and hypoxemia in obstructive sleep apnea syndrome.. Am J Respir Crit Care Med. 1994 Feb;149:416-22.
23. Sajkov D, Wang T, Saunders NA, Bune AJ, Neill AM, Douglas MR. Daytime pulmonary hemodynamics in pa- tients with obstructive sleep apnea without lung disease. Am J Respir Crit Care Med. 1999 ;159:1518-26.
24. Dikmenoğlu N, Ciftçi B, İleri E, et al. Erythrocyte deform- ability, plasma viscosity and oxidative status in patients with severe obstructive sleep apnea syndrome. Sleep Med. 2006 Apr;7:255-61
25. Reinhart WH, Oswald J, Walter R, Kuhn M. Blood vis- cosity and platelet function in patients with obstruc- tive sleep apnea syndrome treated with nasal continu- ous positive airway pressure. Clin Hemorheol Microcirc. 2002;27:201-7.
26. Podszus T, Mayer J, Penzel T, et al. Nocturnalhemodynamics in patients with sleep apnea. Eur J Respir Dis 1986;146:435–42.
27. Hawrylkiewicz I, Palasiewicz G, Plywaczewski R,et al. Pulmonary hypertension in patients with pure obstructive sleep apnea]. Pol Arch Med Wewn 2004;111:449–54
28. Chaouat A, Weitzenblum E, Krieger J, et al. Pulmonary hemodynamics in the obstructive sleep apnea syndrome. Results in 220 consecutive patients.Chest 1996;109:380–6.
29. Bradley TD, Rutherford R, Grossman RF, et al. Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome. Am Rev Respir Dis 1985;131:835–9.
30. Weitzenblum E, Krieger J, Apprill M, et al. Daytime pul- monary hypertension in patients with obstructive sleep apnea syndrome. Am Rev Respir Dis 1988;138:345–9.
31. Chaouat A, Weitzenblum E, Krieger J, et al. Association of chronic obstructive pulmonary disease and sleep apnea syndrome. Am J Respir Crit Care Med 1995;151:82–6.
32. Dursunoglu N, Dursunoglu D, Kilic M. Impact of obstructive sleep apnea on right ventricular global function: sleep apnea and myocardial performance index. Respiration 2005;72:278–84.
33. Sanner BM, Konermann M, Sturm A, et al. Right ventricu- lar dysfunction in patients with obstructive sleep apnoea syndrome. Eur Respir J 1997;10:2079–83.
34. Dursunoglu D, Dursunoglu N, Evrengul H, et al.Impact of obstructive sleep apnoea on left ventricular mass and global function. Eur Respir J 2005;26:283–8.
35. Romero-Corral A, Somers VK, Pellikka PA, et al.Decreased right and left ventricular myocardialperformance in ob- structive sleep apnea. Chest2007;132:1863–70.
36. Otto ME, Belohlavek M, Romero-Corral A, et al.Comparison of cardiac structural and functional changes in obese oth- erwise healthy adults with versus without obstructive sleep apnea. Am J Cardiol 2007;99:1298–302.
37. Gami AS, Hodge DO, Herges RM, et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol 2007;49:565–71.
38. Levy D, Garrison RJ, Savage DD, et al. Prognostic implica- tions of echocardiographically determined left ventricu- lar mass in the Framingham Heart Study. N Engl J Med 1990;322:1561–6.
39. Guidry UC, Mendes LA, Evans JC, et al. Echocardiographic features of the right heart in sleep-disorderedbreathing: the Framingham Heart Study. Am J Respir Crit Care Med 2001;164:933–8.
40. Marrone O Bollero V, Ferrara G, et al. Transmural pres- sure measurements. İmportance in the assessment of pul- monary hypertension in obstructive sleep apneas. Chest 1989; 95:338-342
41. Sajkov D CR, Thornton AT, Espinoza HA, McEvoy RD. Pulmonary hypertension and hypoxemia in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 1994; 149:416-422
42. Marrone O, Bollero V, Pieri D, Salvaggio A, Bonsignore, G. M. Acute effects of oxygen administration on transmural pulmonary artery pressure in obstructive sleep apnea. Chest 1992; 101:1023-1027
43. Emery C SP, Mohammed F, Barer G. The action of hy- percapnia during hypoxia on pulmonary vessels. Bull Eur Physiopathol Respir 1977;
44. Shivalkar B, Van De Heyning C, Kerremans M, Rinkevich D, Verbraecken J, De Backer W, et al. Obstructive Sleep Apnea Syndrome. Journal of the Am Coll Cardiol 2006;47(7):1433–9.
45. Robotham J LW, Holland L, MacGregor D, Bryan, A RJ. Effects of respiration on cardiac performance. J Appl Physiol: Respirat Environ Exercise Physiol 1978; 44:703- 709
46. Scharf SM. Cardiovascular effects of airways obstruction. Lung 1991; 169:1-23
47. Bradley TD. Right and left ventricular function impair- ment and sleep apnea. Clin Chest Med 1992; 13:459-479
48. Chaudary B, Ferguson D, Speir W. Pulmonary edema as a presenting feature of sleep apnea syndrome. Chest 1982; 82:122-124
49. Iwase N, Kikuchi Y, Hida W, et al. Effects of repetitive air- way obstruction on O2 saturation and systemic and pul- monary arterial pressure in anesthetized dogs. Am Rev Respir Dis 1992; 146:1402-1410
50. Garpestad E Katayama H, Parker J, et al. Stroke volume and cardiac output decrease at termination of obstruc- tive apneas. J Appl Physiol 1992;73:1743-1748
51. Iwase N Kikuchi Y, Hida W, et al. Effects of phentolamine and carotid body resection on pulmonary artery and sys- temic artery pressure during repetitive airway obstruc- tion. Am Rev Respir Dis 1989; 39:A181
52. Naeije R, Lejeune P, Leeman M, Melot C, Closset J. Pulmonary vascular responses to surgical chemodenerva- tion and chemical sympathectomy in dogs. J Appl Physiol Rev 1989; 66:42-50
53. Prabhakar NR, Peng YJ, Jacono FJ, Kumar GK, Dick TE. Cardiovascular alterations by chronic intermittent hypox- ia: importance of carotid body chemoreflexes. Clin Exp Pharmacol Physiol. 2005;32:447-449.
54. Allahdadi KJ, Walker BR, Kanagy NL. Augmented endo- thelin vasoconstriction in intermittent hypoxia-induced hypertension. Hypertension. 2005;45:705-709.
55. Rodway GW, Sethi JM, Hoffman LA, et al. İntermittent hypoxia (İH) versus continuous hypoxia (CH): impact on hemodynamic variables and iNOS expression. Sleep. 2005;20:A211
56. Yamauchi M, Nakano H, Maekawa J, et al. Oxidative stress in obstructive sleep apnea. Chest. 2005;127:1674-1679.
57. Teramoto S, Yamamoto H, Yamaguchi Y, Namba R, Ouchi Y. Obstructive sleep apnea causes systemic inflammation and metabolic syndrome. Chest. 2005;127:1074-1075.
58. Kataoka T, Enomoto F, Kim R, et al. The effect of sur- gical treatment of obstructive sleep apnea syndrome on the plasma TNF-alpha levels. Tohoku J Exp Med. 2004;204:267-272.
59. Hawrylkiewicz I, Sliwinski P, Gorecka D, Plywaczewski R, Zielinski J. Pulmonary haemodynamics in patients with OSAS or an overlap syndrome. Monaldi Arch Chest Dis. 2004;61:148-52.
60. Hung TH, Charnock-Jones DS, Skepper JN, Burton GJ. Secretion of tumor necrosis factor-alpha from human pla- cental tissues induced by hypoxia-reoxygenation causes endothelial cell activation in vitro: a potential media- tor of the inflammatory response in preeclampsia. Am J Pathol. 2004;164:1049-1061.. Monaldi Arch Chest Dis. 2004;61:148-152.
61. Sharafkhaneh H, Hirshkowitz M, Sharafkhaneh A, Bozkurt B. Endothelial dependent vascular dilation is abnor- mal in patients with obstructive sleep apnea. Sleep. 2005;20:A210.
62. Lopez-Ramos JC, Martinez-Romero R, Molina F, et al. Evidence of a decrease in nitric oxide-storage molecules following acute hypoxia and/or hypobaria, by means of chemiluminescence analysis. Nitric Oxide. 2005 ;13:62-7.
63. Naughton MT. .The link between obstructive sleep ap- nea and heart failure: underappreciated opportunity for treatment. Curr Cardiol Rep. 2005;7:211-215.
64. Poyares D, Guilleminault C. Sleep and endothelium acti- vation in patients with UARS and severe OSA, preliminary report. Sleep. 2005;20:A196
65. Parish J, Shepard J. Cardiovascular effects of sleep disor- ders. Chest. 1990;97(5):1220–6.
66. Morgenthaler T, Lerman A. Endothelial dysfunction as- sessed by peripheral arterial tonometry in obstructive sleep apnea patients improves with CPAP therapy. Sleep. 2005;20(suppl):A177.
67. Alchanatis M, Tourkohoriti G, Kakouros S, Kosmas E, Podaras S. Daytime pulmonary hypertension in patients with obstructive sleep apnea: the effect of continuous positive airway pressure on pulmonary hemodynamics. Respiration 2001; 68:566-572
68. Sajkov D Wang T, Saunders NA, Bune AJ, McEvoy RD. Continuous positive airway pressure treatment improves pulmonary hemodynamics in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2002; 165:152-158
69. Arias MA Garcia-Rio F, Alonso-Fernandez A, Martinez I, Villamor J. Pulmonary hypertension in obstructive sleep apnoea: effects of continuous positive airway pressure: a randomized, controlled cross-over study. Eur Heart J 2006; 27:1106-1113
70. Fletcher EC, Schaaf JW, Miller J, et al. Long-term car- diopulmonary sequelae in patients with sleep apnea and chronic lung disease. Am Rev Respir Dis 1987;135:525–33.
71. Krieger J, Sforza E, Apprill M, et al. Pulmonary hyper- tension, hypoxemia, and hypercapnia in obstructive sleep apnea patients. Chest 1989;96:729–37.
72. Shinozaki T, Tatsumi K, Sakuma T, et al. Daytime pulmo- nary hypertension in the obstructive sleep apnea syn- drome. Nihon Kyobu Shikkan GakkaiZasshi 1995;33:1073–9
73. Laks L, Lehrhaft B, Grunstein RR, et al. Pulmonary hy- pertension in obstructive sleep apnoea. Eur Respir J 1995;8:537–41.
74. Bady E, Achkar A, Pascal S, et al. Pulmonary arterial hypertension in patients with sleep apnoea syndrome. Thorax 2000;55:934–9.